Polynucleotide Synthesis Service
Polynucleotide Is an Important Substance in Nature
Polynucleotide is a natural polymer that contains 13 or more nucleotide monomers. They are linked by covalent bonds. They form deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
DNAs are the most common polynucleotides that are comprised of sugar deoxyriboses. There are two spiral chains in them. The structure contains diverse bases: adenine, guanine, thymine, and cytosine. They play a crucial role in storing and transmitting genetic information.
RNAs are the most basic polynucleotides in the biological system and possess the pentose sugar riboses. It is an unbranched polynucleotide formed by a single strand. The substance contains four nitrogenous bases, adenine, guanine, cytosine, and uracil. They are classified into several types, such as messenger RNA (mRNA) and transfer RNA (tRNA).
Key Technologies
At CD BioGlyco, our polynucleotide synthesis service leverages solid-phase phosphoramidite chemistry on automated synthesizers for precise DNA/RNA chain assembly, complemented by enzymatic methods using terminal deoxynucleotidyl transferase (TdT) for DNA and T7 RNA polymerase-based in vitro transcription for high-yield RNA synthesis, followed by rigorous PAGE and HPLC purification to deliver high-purity DNA/RNA for research.
Precision-Scaled, Glyco-Engineered: Synthesis Beyond Nucleotides.
CD BioGlyco offers a comprehensive range of techniques for the custom synthesis of DNA and RNA and provides diverse options including chemical custom synthesis and enzymatic custom synthesis.

Custom Chemical DNA Synthesis Service
- Our chemical approach for DNA synthesis couples DNA phosphoramidite nucleosides to a solid support and utilizes a four-step cycle of deblocking, activation, capping, and oxidation to construct the oligonucleotide chain.
Custom Enzymatic DNA Synthesis Service
- In our enzymatic synthesis, we use TdT as the primary enzyme for DNA synthesis.
Custom Hybrid DNA Synthesis Service
- In addition to our DNA synthesis services, we offer the synthesis of DNA hybrids incorporating various inorganic nanomaterials such as gold, magnetic nanoparticles, and silver.

- We offer a solid-phase chemical synthesis approach by using an automated synthesizer. In our method, the RNA chain is elongated step by step on a solid support. We efficiently and precisely synthesize RNA molecules with high purity and yield.
- Our in vitro transcription method uses a DNA template with a T7 RNA polymerase promoter. As a result, our method facilitates efficient synthesis of RNA molecules, leading to high yields usually in the milligram range.
DNA and RNA Purification Service
In addition, we provide DNA and RNA purification services to guarantee purified DNA and RNA for downstream research and applications. We effectively eliminate any unwanted by-products and impurities that may occur during the productive process by our technologies, including PAGE-based Purification Service and HPLC-based Purification Service.
Fig.1 The technologies of purification. (CD BioGlyco)
Workflow
Our polynucleotide synthesis workflow is designed for efficiency, quality, and scalability. Each step is carefully controlled and monitored to ensure the final product meets the highest standards.
- Project Consultation and Design
Our experts work with you to understand your project's specific needs, including sequence, length, scale, and modifications. We then recommend the optimal synthesis and purification strategy (chemical, enzymatic, or a hybrid approach) to achieve your goals.
- Synthesis
Based on the project design, the custom polynucleotide is synthesized. For chemical synthesis, this involves the automated, stepwise addition of phosphoramidite monomers. For enzymatic synthesis, it involves the controlled, enzyme-catalyzed addition of nucleotides to build the sequence.
- Deprotection and Cleavage
After synthesis is complete, the protecting groups are removed from the polynucleotide, and the newly synthesized strand is cleaved from the solid support.
- Purification
The crude synthesis mixture, which contains the full-length product along with truncated fragments and other impurities, is then purified using one of our advanced purification services (e.g., PAGE, HPLC, Cartridge-based). This critical step ensures the removal of contaminants and the delivery of a high-purity product.
- Quality Control and Final Delivery
Every synthesized and purified polynucleotide undergoes rigorous quality control, including mass spectrometry and capillary electrophoresis, to verify its sequence and purity.
Publication Data
DOI.: 10.3390/app12031543
Journal: Applied Sciences
Published: 2022
IF: 2.5
Results: Scrupulous comparative evaluation confronts dichotomous fabrication paradigms: synthetic chemical pathways (operative within abbreviated nucleotide sequences) and enzymatic in vitro transcription systems (preferable for extended polynucleotide architectures). Meticulous deconstruction follows regarding each technique's fundamental mechanisms, catalytic efficiencies, inherent constraints, and practical implementation logistics. Crucially, the investigation incorporates empirical observations derived from systematic experimentation quantifying yield optimization across diverse RNA molecular topologies. This taxonomic endeavor ultimately constructs an intellectual scaffold enabling researchers to implement determinative selection frameworks—balancing chemical precision against transcriptional scalability—when confronting particular ribonucleic acid targets intended for structural interrogation at industrial production thresholds.
Applications
- Interference RNA is applied for researching the functions of genes in cell culture and model organisms
- Recombinant DNA can be used to produce human insulin, eliminating the reliance on animal sources and enabling its widespread usage in the pharmaceutical industry.
- DNA technology is useful in agriculture. It enhances crop yield by transferring certain genes and increases nutrition value and shelf life by modifying certain genes.
- DNA can be used in RFLP and STR to identify suspects.
Advantages
- We utilize advanced polynucleotide synthesis techniques and optimal synthesis methods to ensure the accuracy and integrity of the structures.
- Our synthesis process undergoes rigorous quality control measures to provide reliable and consistent results.
- We have advanced PAGE and HPLC technologies to purity those polynucleotides we custom to ensure our quality of service.
Frequently Asked Questions
Associated Services
Our polynucleotide synthesis service delivers high-purity DNA/RNA sequences tailored to your length and modification requirements. To ensure these synthetic products meet application-specific purity standards, we provide specialized Oligonucleotide Fragment Purification Services, each optimized for critical impurity removal:
CD BioGlyco is a leader in the field of glycobiology, we are committed to offering carbohydrate synthesis services to meet your specific needs. We provide accurate and efficient synthesis solutions with our advanced techniques. With our simple processes and efficient project management, we guarantee the perfect completion of the service within the agreed time. Feel free to contact us as soon as possible if you are interested in our services.
Reference
- Ryczek, M.; et al. Overview of methods for large-scale RNA synthesis. Applied Sciences. 2022, 12(3): 1543. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




